Navigation Links
Process Analytical Technology: The Future of Pharmaceutical Manufacturing is Now
Date:5/7/2013

WASHINGTON DC, May 7, 2013 /PRNewswire/ --

Process Analytical Technology (PAT) is quickly becoming an integral component in the pharmaceutical and chemical manufacturing industries.  Utilizing a low latency network of powerful chemometric instruments, multivariate data analysis software, process control tools, and a central SQL database, PAT provides pharmaceutical and biopharmaceutical companies an edge over their competitors. 

PAT and its benefits are incredible and groundbreaking. Done are they days of a rigid manufacturing line and discarded low-quality batches due to the unforeseen consequences of factory automation "improvements". Instead, PAT is a flexible system capable of keeping pace with the rapid advances in drug development and manufacture. At the core of any PAT system are a set of Critical Process Parameters (CPPs) that are defined based on the manufacturing equipment itself, and those CPPs will function as the independent variables along the production line. By monitoring physical and chemical properties, the manufacturer can also define a set of variable CPP-dependent variables known as Critical Quality Attributes (CQAs) at various stages of the process, allowing the manufacturer to better understand and control the entire process. These CPPs and CQAs are then used in conjunction with a PAT platform to create both unit-level and high-level process line models capable of predicting the precise quality of the end product. After the predictions are made, adjustments can be made and be fed back into integrated control systems such as Siemens SIMATIC PCS7, fine tuning the manufacturing process to further improve product quality and ensure product consistency.

PAT platforms have been developed by automation industry leaders such as Siemens, and current PAT solutions are supported by a vast number of major analyzer manufacturers such as Mettler Toledo, Thermo Scientific, Kaiser Optical Systems, and the Bruker corporation. The Siemens implementation (SIPAT) is configured to work with these manufacturers by default, however SIPAT will integrate with nearly any analyzer, including those capable of NIR spectroscopy, NMR spectroscopy, or FBRM.

Non-destructive on-line or at-line testing of the product allows the manufacturer to achieve Real Time Release Testing (RTRT) that has been specifically cited by the FDA to increase economic benefit and manufacturing efficiency by lowering laboratory costs and reducing inventory. An FDA white paper from 2004 delves deeper into the benefits of, and can be found at http://www.fda.gov/downloads/Drugs/Guidances/ucm070305.pdf

As an experienced PAT/automation engineer at Panacea Technologies, Inc., Jake Newberger has worked with a major pharmaceutical company to install, upgrade, and expand a worldwide network of over 50 chemometric analyzers, collectors, and base stations. In addition, Jake Newberger has provided support to half a dozen manufacturing facilities across the globe, for several different product runs, including those in both the development and production stages. 

As modern medicine continues to advance at breakneck speed, the technology used to scale up and manufacture those advances will have to keep pace. PAT is not just evolutionary, but truly revolutionary, analogous to the advent of batch processing twenty years ago, which has now become the industry standard. 

A graduate of Penn State's top-ranked mechanical engineering program,  Jake Newberger is an Automation Engineer at Panacea Technologies, Inc., located outside of Philadephia.


'/>"/>
SOURCE Panacea Technologies Inc
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Rigaku Publishes Method for Process Elemental Analysis of Chemical Bath for Copper Foil Surface Treatment
2. ProcessBarron to Co-Host Annual Jansen Boiler Workshop
3. White Mountain Process Announces Sanitary Autoclave Style Pharmaceutical Agitator
4. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
5. Three Dispensing Modes Featured in the New Masterflex I/P Digital Brushless Process Drives from Cole-Parmer
6. Rigaku Announces New EDXRF Method for Elemental Analysis in Gold Processing
7. Credit Card Processor CPN’s Water Filter Donation Reaches Haiti
8. Risk Assessment and Mitigation in Phase I Trials in High Risk Compounds: A Continuously Developing Process, new life science webinar hosted by Xtalks
9. Leading Biotoxin & Mold Illness Authority Creates Certification Process for Treatment Protocol
10. BioProcess International March 2013 Issue Published on the App Store Featuring App-only Exclusive Content
11. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... ... ... Huffman Engineering, Inc. , a leader in control systems integration, today ... office as a chemical engineer. In his new role, Beck will use his ... science manufacturing and water/wastewater industries. , Prior to joining Huffman Engineering, Beck served for ...
(Date:1/12/2017)... , January 12, 2017 The ... world,s biggest facility for producing mycorrhizae. The Centre for ... tapping potential of mycorrhizae and developed a technology that ... ... The TERI facility has a ...
(Date:1/12/2017)... Pune, India , January 12, 2017 A new ... Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that ... $2,921 million in 2015, growing at a CAGR of 15.07% during the forecast period. ... ... Market Research Logo ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... of Limfinity® Cloud, RURO has enhanced the platform to accommodate increasingly complex ... login, rapid data searching, and more. In addition to these improvements, the ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
Breaking Biology News(10 mins):